Belun remoVital
Continuous vital sign monitoring system for residential care facilities
Company profile
Company profile
Belun Technology is a medical device company founded in 2016 that specializes in AI-powered wearable technology for sleep diagnostics and remote patient monitoring. Headquartered in Hong Kong and Singapore with R&D operations in Taiwan, Belun has developed the world's first FDA 510(k)-cleared wearable ring system for obstructive sleep apnea (OSA) diagnosis. The company's flagship Belun Ring captures SpO₂, pulse rate, HRV, and PPG signals overnight, while its proprietary Belun Sleep System uses deep learning algorithms trained on over 200 million PSG data segments to provide comprehensive sleep apnea reports validated against polysomnography. Belun serves healthcare providers, sleep clinics, and patients across multiple markets including the United States, Singapore, Taiwan, India, Thailand, Malaysia, Indonesia, New Zealand, and Australia. The platform addresses a critical global health gap where up to 80% of OSA cases remain undiagnosed due to limited access to traditional in-lab sleep studies. Working closely with medical experts in sleep medicine, cardiology, psychology, and psychiatry, Belun has generated over 150,000 sleep reports worldwide and demonstrated clinical impact including 56% reduction in OSA waiting times. The company's technology supports both individual wellness management and professional medical workflows, enabling scalable sleep diagnostics from diagnosis through longitudinal monitoring and treatment titration.
Company description Belun Technology Company official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid deployment with recorded integration context.
Company milestones
FDA 510(k) clearance for world's first AI-powered wearable ring system for OSA diagnosis; deployment to 60+ residential care homes; generation of 150,000+ sleep reports worldwide
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Continuous vital sign monitoring system for residential care facilities
FDA-cleared wearable ring for medical-grade sleep diagnostics and continuous monitoring
World's first AI-powered wearable ring system for OSA diagnosis with sleep staging
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Progress in molecular biology and translational science · Jan 1, 2025
Assessing sleep metrics in stroke survivors: a comparison between objective and subjective measures.Sleep & breathing = Schlaf & Atmung · Dec 4, 2024
Belun Ring (Belun Sleep System BLS-100): Deep learning-facilitated wearable enables obstructive sleep apnea detection, apnea severity categorization, and sleep stage classification in patients suspected of obstructive sleep apnea.Sleep health · Aug 1, 2023
The Belun sleep platform to diagnose obstructive sleep apnea in patients with hypertension and high cardiovascular risk.Journal of hypertension · Jun 1, 2023
Detection of obstructive sleep apnea using Belun Sleep Platform wearable with neural network-based algorithm and its combined use with STOP-Bang questionnaire.PloS one · Jan 1, 2021
Belun Ring Platform: a novel home sleep apnea testing system for assessment of obstructive sleep apnea.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Sep 15, 2020
Clinical validation
NCT07785999 · Sponsor · RECRUITING
Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep ApneaNCT04121923 · Sponsor · COMPLETED
Belun Ring Platform With an Improved Algorithm for OSA AssessmentNCT04885062 · Sponsor · COMPLETED
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body SensorNCT06255613 · Sponsor · ACTIVE NOT RECRUITING
Ring-type Pulse Oximeter for Evaluation for Sleep Assessment StudyNCT06221124 · Sponsor · COMPLETED
Belun Ring Validation Study for Assessment of Obstructive Sleep ApneaNCT03997916 · Sponsor · COMPLETED
Regulatory
K222579 · 510k · Feb 23, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
104 weeks reduced to 45 weeks (Young et al., Respirology, 2023)
27 days average treatment time (Tozzer et al., AADSM 2025)
Worldwide deployment across multiple markets
Mandibular Advancement Device (MAD) titration for sleep apnea treatment
27 days average treatment time with 90% success rate using rapid titration protocol
Reducing wait times for OSA diagnosis
56% reduction in OSA waiting time from 104 weeks to 45 weeks
Continuous vital sign monitoring for elderly residents
Deployed to 60+ residential care homes, automated health monitoring with immediate alerts for abnormal vital signs
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Belun Technology Company's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.